Apogee Therapeutics

1. APG279 Ph1 readout2H 2026APG279 Ph1 readout, 2H 2026, major
2. APG279 readout2H 2026APG279 readout, 2H 2026, major
3. Zumilokibart Ph3 start2H 2026Zumilokibart Ph3 start, 2H 2026, notable
4. APG273 corporate update2H 2026APG273 corporate update, 2H 2026, routine
5. Deal Closing FDA decision2H 2026Deal Closing FDA decision, 2H 2026, routine
6. Merger Agreement partnership3Q 2026Merger Agreement partnership, 3Q 2026, routine
7. Zumilokibart Ph2 readout1H 2027Zumilokibart Ph2 readout, 1H 2027, material

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.